Enzymatica has concluded an agreement with Apotek Hjärtat, Sweden’s second largest pharmacy chain. During February 2013, Enzymatica’s medical device product, ColdZyme® Mouth Spray, will be introduced as part of the product range at Apotek Hjärtat.
“The agreement signed with the Apotek Hjärtat pharmacy chain serves as further confirmation of the interest in our products. The Apotek Hjärtat pharmacy chain is Sweden’s second largest pharmacy group, with some 270 pharmacies nationwide,” notes Michael Edelborg Christensen, CEO at Enzymatica.
Enzymatica’s registered product, ColdZyme® Mouth Spray, will be on sale as part of the regular product range at Apotek Hjärtat, with its introduction as of February.
“The agreements concluded with two of the leading pharmacy chains – Apotek Hjärtat and Kronans Droghandel – mean that ColdZyme® Mouth Spray will be on sale throughout almost 50 percent of all pharmacies in Sweden. Negotiations with other pharmacy groups are proceeding according to plan,” adds Michael Edelborg Christensen.
For more detailed information, contact:
Michael Edelborg Christensen, CEO, Enzymatica AB (publ), 0768-14 41 66, firstname.lastname@example.org